BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Aratana Therapeutics to Present at Biotech Showcase 2013


1/2/2013 8:57:45 AM

KANSAS CITY, Kan. and NEW YORK, Jan. 2, 2013 /PRNewswire/ -- Aratana Therapeutics, an animal health company developing innovative medicines for cats and dogs (companion animals), announced today that president and CEO Steven St. Peter, M.D. will be presenting at the Biotech Showcase 2013 Conference being held in San FranciscoJanuary 7-9, 2013. Dr. St. Peter will provide an overview of the company's companion animal medicine programs and development strategy.

Details of Aratana's presentation are as follows:

Event:


Biotech Showcase 2013 Conference

Date:


Tuesday, January 8, 2013

Time:


5:00pm PST

Location:


Hearst room; Parc 55 Wyndham San Francisco Union Square Hotel

Co-produced by EBD Group and Demy-Colton Life Science Advisors, Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences.

About Aratana Therapeutics

Aratana Therapeutics is an animal health drug development company uniquely positioned to deliver high quality new medicines that address significant therapeutic needs for cats and dogs (companion animals). Aratana licenses and develops proprietary, patent-protected compounds acquired from human pharmaceutical and biotechnology companies and then develops strategies to maximize the value of the programs for the animal health market. For more information, please visit www.aratanatherapeutics.com.

For Investors & Media:
Joshua Drumm, Ph.D. / Andrew Mielach
Tiberend Strategic Advisors, Inc.
(212) 827-0020
jdrumm@tiberend.com
amielach@tiberend.com

SOURCE Aratana Therapeutics



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES